Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients

Mediators of Inflammation

Volumn 12, Issue 4, 2003, Pages 221-227

  Antonopoulou, Smaragdi ^a   Tsoupras, Alexandres ^b   Baltas, George ^b   Kotsifaki, Helen ^b   Mantzavinos, Zacharias ^b   Demopoulos, Constantinos A ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Electrospray mass spectrometry; Gingival crevicular fluid; Periodontal disease; Phospholipids; Platelet activating factor

Indexed keywords

HYDROXYL GROUP; THROMBOCYTE ACTIVATING FACTOR DERIVATIVE;

ADULT; ARTICLE; BIOASSAY; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; ANIMALS; BIOLOGICAL ASSAY; BLOOD PLATELETS; GINGIVAL CREVICULAR FLUID; HUMANS; LIPID METABOLISM; LIPIDS; MALE; PERIODONTITIS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; RABBITS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 0142093536     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350310001599666     Document Type: Article

References (27)

1. Socransky SS, Haffajee AD. Evidence of bacterial etiology: a historical perspective. Periodontol 1994; 2000: 7-25.
2. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol 1996; 67: 1123-1137.
3. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991; 26: 230-242.
4. Emingil G, Cinarcik S, Baylas H, Huseyinov A. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases. J Periodontol 2001; 72: 1032-1037.
5. Baltas G, Kotsifaki H, Antonopoulou S, Kipioti A, Demopoulos CA. Implication of PAF and acetylhydrolase (PAF-AH) activity in periodontal disease. Adv Exp Med Biol 1996; 416: 135-141.
6. Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphoryl-choline as the active component. (A new class of lipid chemical mediators.). J Biol Chem 1979; 254: 9355-9358.
7. Antonopoulou S, Demopoulos CA, Argyropoulos D, Baltas G, Kotsifaki H, Diamanti-Kipioti A. Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid. Biochem J 1998; 330: 791-794.
8. McManus LM, Pinckard RN. PAF, a putative mediator of oral inflammation. Crit Rev Oral Biol Med 2000; 11: 240-258.
9. McManus LM, Marze BT, Schiess AV. Deficiency of salivary PAF in edentulous individuals. J Periodontal Res 1990; 25: 347-351.
10. Ribaldi E, Guerra M, Mezzasoma AM, Staffolani N, Goracci G, Gresele P. PAF levels in saliva are regulated by inflammatory cells. J Periodontal Res 1998; 33: 237-241.
11. Armitage GC. Periodontal infections and cardiovascular disease-how strong is the association? Oral Dis 2000; 6: 335-350.
12. Kolltveit KM, Eriksen HM. Is the observed association between periodontitis and atherosclerosis cause? Eur J Oral Sci 2001; 109: 2-7.
13. Beck JD, Pankow J, Tyroler HA, Offenbacher S. Dental infections and atherosclerosis. Am Heart J 1999; 138: S528-S533.
14. Kinane DF. Periodontal diseases contributions to cardiovascular disease: an overview of potential mechanism. Ann Periodontol 1998; 3: 142-150.
15. Triggiani M, Schleimer RP, Warner JA, Chilton FH. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. J Immunol 1991; 146: 660-666.
16. Tokumura A, Sumida T, Toujima M, Kogure K, Fukuzawa K. Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis. Biofactors 2000; 13: 29-33.
17. Brocheriou I, Stengel D, Mattsson-Hulten L, et al. Expression of platelet-activating factor receptor in human cardiovascular atherosclerotic plaques: relevance to progression of atherosclerosis. Circulation 2000; 21: 2569-2575.
18. Montrucchio G, Alloatti G, Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Phys Rev 2000; 80: 1669-1699.
19. Liapikos TA, Antonopoulou S, Karabina SA, Tsoukatos DC, Demopoulos CA, Tselepis AD. Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated. Biochim Biophys Acta 1994; 1212: 353-360.
20. Karantonis HC, Antonopoulou S, Demopoulos CA. A biochemical approach of the antiatherogenic properties of olive oil and its protective role against coronary heart disease. Proceedings of the 93rd AOCS Annual Meeting & Expo, Montreal, Quebec, 5-8 May.
21. Stafforini DM, McIntyne TM, Carter ME, Prescott SM. Human plasma platelet-activating factor acetylhydrolase. J Biol Chem 1987; 262: 4223-4230.
22. Demopoulos CA, Andrikopoulos NK, Antonopoulou S. A simple and precise method for the routine determination of platelet-activating factor in blood and urine. Lipids 1994; 29: 305-309.
23. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
24. Nomikos T, Karantonis HC, Fragopoulou E, Demopoulos CA. One step separation system for the main phospholipids, glycolipids and phenolics by normal phase HPLC. Application to polar lipids extracts from olive and sunflower oils. J Liquid Chromatogr Rel Technol 2002; 25: 137-149.
25. Lazanas M, Demopoulos CA, Tournis S, Koussissis S, Labrakis-Lazanas K, Tsarouhas X. PAF of biological fluids in disease: IV. Levels in blood in allergic reactions induced by drugs. Arch Dermatol Res 1988; 280: 124-126.
26. Brugger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci USA 1997; 94: 2339-2344.
27. Khaselev N, Murphy RC. Electrospray ionization mass spectrometry of lysoglycerophosphocholine lipid subclasses. J Am Soc Mass Spectrom 2000; 11: 283-291.